Dr Lal Pathlabs informs about impact of covid 19 pandemic

02 Jun 2020 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, Dr Lal Pathlabs has informed that it has submitted the disclosure of material impact of COVID-19 pandemic on the business and operations of the Company.

The above information is a part of company’s filings submitted to BSE.


Dr. Lal Pathlabs Share Price

1375.35 -43.05 (-3.04%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6801.30
Max Healthcare Inst 991.50
Narayana Hrudayalay 1749.05
Aster DM Healthcare 555.35
Global Health 1029.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×